Cargando…

Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study

INTRODUCTION: The most common classification of acute myocardial infarction (AMI) is based on electrocardiographic findings and distinguishes ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Both types of AMI differ concerning their epidemiology, clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamski, Piotr, Ostrowska, Małgorzata, Sikora, Joanna, Obońska, Karolina, Buszko, Katarzyna, Krintus, Magdalena, Sypniewska, Grażyna, Marszałł, Michał Piotr, Koziński, Marek, Kubica, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541360/ https://www.ncbi.nlm.nih.gov/pubmed/28446521 http://dx.doi.org/10.1136/bmjopen-2016-013218

Ejemplares similares

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial
por: Kubica, Jacek, et al.
Publicado: (2015)

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial
por: Kubica, Jacek, et al.
Publicado: (2016)

Value of C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome: A Comparison with Apolipoprotein Concentrations and Lipid Profile
por: Krintus, Magdalena, et al.
Publicado: (2012)

Metabolism of ticagrelor in patients with acute coronary syndromes
por: Adamski, Piotr, et al.
Publicado: (2018)

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2019)

Pharmacokinetic Modeling of Morphine’s Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers
por: Buszko, Katarzyna, et al.
Publicado: (2021)

Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial
por: Niezgoda, Piotr, et al.
Publicado: (2022)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

Multi-Marker Approach with the Use of Biochip Cardiac Array Technology for Early Diagnosis in Patients with Acute Coronary Syndromes
por: Sawicki, Marcin, et al.
Publicado: (2008)

The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial
por: Obońska, Karolina, et al.
Publicado: (2017)

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study
por: Niezgoda, Piotr, et al.
Publicado: (2022)

Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study — preliminary results
por: Obońska, Karolina, et al.
Publicado: (2021)

Analysis of STEMI and NSTEMI in a Community Cohort of Marijuana Users
por: Jean-Louis, Farla, et al.
Publicado: (2022)

Pretreatment with P2Y(12) Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?
por: Niezgoda, Piotr, et al.
Publicado: (2023)

Late STEMI and NSTEMI Patients’ Emergency Calling in COVID-19 Outbreak
por: Trabattoni, Daniela, et al.
Publicado: (2020)

Predictors of Long-Term Outcome in STEMI and NSTEMI—Insights from J-MINUET
por: Lechner, Ivan, et al.
Publicado: (2020)

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
por: Teng, Renli
Publicado: (2015)

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
por: Dobesh, Paul P, et al.
Publicado: (2014)

Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development
por: Žaliaduonytė-Pekšienė, Diana, et al.
Publicado: (2017)

Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome
por: Charach, Lior, et al.
Publicado: (2021)

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs after Vaccination (DANTE-SIRIO 7) Study in a Large Cohort of Healthcare Workers
por: Krintus, Magdalena, et al.
Publicado: (2022)

The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events
por: Magdalena, Krintus, et al.
Publicado: (2006)

Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction
por: Swiatkiewicz, Iwona, et al.
Publicado: (2012)

Value of C-Reactive Protein in Predicting Left Ventricular Remodelling in Patients with a First ST-Segment Elevation Myocardial Infarction
por: Swiatkiewicz, Iwona, et al.
Publicado: (2012)

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial
por: Kubica, Jacek, et al.
Publicado: (2022)

Does ticagrelor effectively inhibit platelets in patients undergoing mild therapeutic hypothermia or it does not?
por: Kubica, Jacek
Publicado: (2022)

Synthesized 18-Lead Electrocardiogram in Diagnosing Posterior Stemi-Equivalent Acute Coronary Syndrome in Patients with NSTEMI
por: Horie, Tomoki, et al.
Publicado: (2022)

ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial
por: Kubica, Aldona, et al.
Publicado: (2021)

Comparison of Apolipoprotein Concentrations and Values of APOB:APOAI with Traditional Lipid Measures in Women Diagnosed with Acute Cornonary Syndromes – A Preliminary Report
por: Krintus, Magdalena, et al.
Publicado: (2011)

Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity
por: Murawska, Karolina, et al.
Publicado: (2021)

Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women
por: Stefanska, Anna, et al.
Publicado: (2022)

Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
por: Teng, Renli, et al.
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function
por: Teng, Renli, et al.
Publicado: (2018)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

Shock index and modified shock index are predictors of long-term mortality not only in STEMI but also in NSTEMI patients
por: Schmitz, Timo, et al.
Publicado: (2022)

Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction
por: Takeji, Yasuaki, et al.
Publicado: (2021)

DID THE COVID-19 PANDEMIC CAUSE PATIENTS WITH TYPE I STEMI OR NSTEMI TO DELAY SEEKING MEDICAL ATTENTION?
por: Wagle, Sugat, et al.
Publicado: (2022)

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing
por: Ostrowska, Małgorzata, et al.
Publicado: (2019)

Non-fasting lipid profile determination in presumably healthy children: Impact on the assessment of lipid abnormalities
por: Szternel, Lukasz, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lbd5r67fps2bft4mrngdr54fuo